Showing 2754 results
-
Ad hoc release /MEDIA & INVESTOR RELEASE Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard-of-care TKIs in Phase III trial for newly diagnosed patients with chronic…
Pagination
- ‹ Previous page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- …
- 276
- › Next page